Novocure develops cancer treatment technologies and related support services. Its products help hospitals, doctors, and adult cancer patients manage solid tumors through noninvasive therapy and treatment planning.
Novocure products and services overview:
Revenue: ~$605 million
Employees: 1,400
Headquarters: Portsmouth, United States (USA)
Novocure is one of the...
Novocure is a company listed under the stock ticker NVCR (US).
View the org chart displaying its 26 main executives
Create your alert
to follow the executive moves at Novocure.
Novocure has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.